GGrantIndex
← Leaderboards

Alla Sikorskii

Michigan State University

$4,293,065
Attributed
$9,235,802
Total exposure
4
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,235,802 · 4

By mechanism

R01$9,235,802 · 4

Top collaborators

Most similar at Michigan State University

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseRandomizedPrimary OutcomeFatigueSymptom ManagementSymptomsAnxietyEvidence BaseMalignant NeoplasmsSurvivorsDiagnosisDesignSeveritiesSymptomatic ImprovementCancer SurvivorCounselingMental DepressionSecondary OutcomeCharacteristicsIndexingSymptom Self ManagementCancer TherapyTelephoneTrial Design

Grant awards (15)

Managing symptoms and psychological distress during oral anti-cancer treatment$645,804
R01 · FY2025 · CA · contact PI
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors$643,900
R01 · FY2025 · CA
Managing symptoms and psychological distress during oral anti-cancer treatment$613,476
R01 · FY2024 · CA · contact PI
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors$613,316
R01 · FY2024 · CA
Managing symptoms and psychological distress during oral anti-cancer treatment$689,739
R01 · FY2023 · CA · contact PI
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors$637,302
R01 · FY2023 · CA
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors$650,104
R01 · FY2022 · CA
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design$614,226
R01 · FY2021 · CA
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design$730,620
R01 · FY2020 · CA
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design$599,567
R01 · FY2019 · CA
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients$487,663
R01 · FY2019 · CA
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design$632,908
R01 · FY2018 · CA
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients$554,574
R01 · FY2018 · CA
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients$556,045
R01 · FY2017 · CA
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients$566,558
R01 · FY2016 · CA